|
27 Jul 2020 |
MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan
|
|
27 Jul 2020 |
Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19
|
|
23 Jul 2020 |
Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
|
|
23 Jul 2020 |
Valneva Announces Positive Initial Results for Phase 2 Study of Lyme Disease Vaccine Candidate
|
|
22 Jul 2020 |
Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers
|
|
22 Jul 2020 |
Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
|
|
22 Jul 2020 |
Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies
|
|
21 Jul 2020 |
Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, LUNAR-COV19
|
|
20 Jul 2020 |
Metaclipse Therapeutics Awarded Funding from NIAID for COVID-19 Vaccine Development
|
|
20 Jul 2020 |
Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
|
|
20 Jul 2020 |
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
|
|
20 Jul 2020 |
GSK and CureVac announce strategic mRNA technology collaboration
|
|
20 Jul 2020 |
Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2
|
|
17 Jul 2020 |
Applied DNA and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
|
|
16 Jul 2020 |
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
|
|
16 Jul 2020 |
Virometix Announces Successful Closing of Series B Investment Round raising CHF 7.5 million
|
|
16 Jul 2020 |
AC Immune Advances phospho-Tau Alzheimer’s Vaccine in Phase 1b/2a Study
|
|
15 Jul 2020 |
COVAXX Announces First Multitope Peptide-Based Vaccine to Enter Human Trials
|
|
15 Jul 2020 |
ZYUS Announces Positive Milestone in Plant-Based COVID-19 Vaccine Antigen Production
|
|
15 Jul 2020 |
Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273)
|
|
15 Jul 2020 |
Zydus starts human dosing of its vaccine ‘ZyCoV-D’
|
|
14 Jul 2020 |
Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA
|
|
14 Jul 2020 |
Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate
|
|
14 Jul 2020 |
IMV Updates Rapid Progress on COVID-19 Vaccine Program
|
|
13 Jul 2020 |
Altimmune and the University of Alabama at Birmingham (UAB) Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID™
|
